2012 Articles
Novel therapeutic agents for cutaneous T-Cell lymphoma
Mycosis fungoides (MF) and Sezary Syndrome (SS) represent the most common subtypes of primary Cutaneous T-cell lymphoma (CTCL). Patients with advanced MF and SS have a poor prognosis leading to an interest in the development of new therapies with targeted mechanisms of action and acceptable safety profiles. In this review we focus on such novel strategies that have changed the treatment paradigm of this rare malignancy.
Files
-
32d42a4b235050469b52cfb99ea48d6a.zip application/zip 286 KB Download File
-
1756-8722-5-24.pdf application/pdf 334 KB Download File
-
1756-8722-5-24.xml application/xml 136 KB Download File
Also Published In
- Title
- Journal of Hematology and Oncology
- DOI
- https://doi.org/10.1186/1756-8722-5-24
More About This Work
- Academic Units
- Medicine
- Publisher
- BioMed Central
- Published Here
- September 8, 2014